A global research priority agenda to advance public health responses to fatty liver disease
Jeffrey V. Lazarus,Henry E. Mark,Alina M. Allen,Juan Pablo Arab,Patrizia Carrieri,Mazen Noureddin,William Alazawi,Naim Alkhouri,Saleh A. Alqahtani,Marco Arrese,Ramon Bataller,Thomas Berg,Paul N. Brennan,Patrizia Burra,Graciela E. Castro-Narro,Helena Cortez-Pinto,Kenneth Cusi,Nikos Dedes,Ajay Duseja,Sven M. Francque,Hannes Hagström,Terry T.-K. Huang,Dana Ivancovsky Wajcman,Achim Kautz,Christopher J. Kopka,Aleksander Krag,Veronica Miller,Philip N. Newsome,Mary E. Rinella,Diana Romero,Shiv Kumar Sarin,Marcelo Silva,C. Wendy Spearman,Emmanuel A. Tsochatzis,Luca Valenti,Marcela Villota-Rivas,Shira Zelber-Sagi,Jörn M. Schattenberg,Vincent Wai-Sun Wong,Zobair M. Younossi,Healthy Lives Collaborators Healthy Livers,Jeffrey V. Lazarus,Henry E. Mark,Alina M. Allen,Juan Pablo Arab,Patrizia Carrieri,Mazen Noureddin,William Alazawi,Naim Alkhouri,Saleh A. Alqahtani,Marco Arrese,Ramon Bataller,Thomas Berg,Paul N. Brennan,Patrizia Burra,Graciela E. Castro-Narro,Helena Cortez-Pinto,Kenneth Cusi,Nikos Dedes,Ajay Duseja,Sven M. Francque,Hannes Hagström,Terry T-K. Huang,Dana Ivancovsky Wajcman,Achim Kautz,Christopher J. Kopka,Aleksander Krag,Veronica Miller,Philip N. Newsome,Mary E. Rinella,Diana Romero,Shiv Kumar Sarin,Marcelo Silva,C. Wendy Spearman,Emmanuel A. Tsochatzis,Luca Valenti,Marcela Villota-Rivas,Shira Zelber-Sagi,Jörn M. Schattenberg,Vincent Wai-Sun Wong,Zobair M. Younossi,Fredrik Aberg,Leon Adams,Khalid Al-Naamani,Reda M. Albadawy,Zinaida Alexa,Michael Allison,Faisal A. Alnaser,Khalid Alswat,Mario Reis Alvares-da-Silva,Domenico Alvaro,Michele Alves-Bezerra,Raul J. Andrade,Quentin M. Anstee,Yaw Asante Awuku,Oidov Baatarkhuu,Gyorgy Baffy,Shokhista Bakieva,Meena B. Bansal,Robert Barouki,Rachel L. Batterham,Cynthia Behling,Renata Belfort-DeAguiar,Annalisa Berzigotti,Michael Betel,Cristiana Bianco,Emanuele Bosi,Jerome Boursier,Elizabeth M. Brunt,Elisabetta Bugianesi,Christopher J. Byrne,Maria Cecilia Cabrera Cabrejos,Stephen Caldwell,Rotonya Carr,Marlen Ivón Castellanos Fernández,Laurent Castera,Maria Gabriela Castillo-López,Cyrielle Caussy,Eira Cerda-Reyes,Antonio Ceriello,Wah- Kheong Chan,Yoosoo Chang,Phunchai Charatcharoenwitthaya,Norberto Chavez-Tapia,Raymond T. Chung,Massimo Colombo,Kirsten Coppell,Helma P. Cotrim,Antonio Craxi,Javier Crespo,Anuradha Dassanayake,Nicholas O. Davidson,Robert De Knegt,Victor de Ledinghen,Münevver Demir,Hailemichael Desalegn,Moises Diago,John F. Dillon,Bruce Dimmig,M. Ashworth Dirac,Melisa Dirchwolf,Jean-François Dufour,Karel Dvorak,Mattias Ekstedt,Mohamed El-Kassas,Osama M. Elsanousi,Ahmed M. Elsharkawy,Reda Elwakil,Wayne Eskridge,Mohammed Eslam,Gamal Esmat,Jian- Gao Fan,Maria Lucia Ferraz,Robert Flisiak,Davide Fortin,Yasser Fouad,Scott L. Freidman,Michael Fuchs,Adrian Gadano,Amalia Gastaldelli,Anja Geerts,Andreas Geier,Jacob George,Lynn H. Gerber,Hasmik Ghazinyan,Liana Gheorghe,Denise Giangola Kile,Marcos Girala,George Goh Boon Bee,Nicolas Goossens,Isabel Graupera,Henning Grønbæk,Saeed Hamid,Vanessa Hebditch,Zachary Henry,Ingrid J. Hickman,L. Ansley Hobbs,Samantha L. Hocking,Wolf Peter Hofmann,Ramazan Idilman,Paula Iruzubieta,Scott Isaacs,Vasily A. Isakov,Mona H. Ismail,Mohammad H. Jamal,Helen Jarvis,Peter Jepsen,François Jornayvaz,K.C. Sudhamshu,Satoru Kakizaki,Saul Karpen,Takumi Kawaguchi,Shelley E. Keating,Yousef Khader,Seung Up Kim,Won Kim,David E. Kleiner,Ger Koek,Narcisse Patrice Joseph Komas,Loreta A. Kondili,Bart G. Koot,Marko Korenjak,Eleni Kotsiliti,Yiannoula Koulla,Carina Kugelmas,Marcelo Kugelmas,Asma Labidi,Naomi F. Lange,Joel E. Lavine,Mariana Lazo,Nathalie Leite,Han-Chieh Lin,Undram Lkhagvaa,Michelle T. Long,Patricio Lopez-Jaramillo,Adelina Lozano,Maria Paula Macedo,Reza Malekzadeh,Giulio Marchesini,Sebastian Marciano,Kim Martinez,Sophia E. Martínez Vázquez,Lyudmila Mateva,José M. Mato,Charles Mbendi Nlombi,Alexis Gorden McCary,Jeff McIntyre,Martin McKee,Juan M. Mendive,Ivana Mikolasevic,Pamela S. Miller,Tamara Milovanovic,Terri Milton,Rosalba Moreno-Alcantar,Timothy R. Morgan,Ayesha Motala,Jean Muris,Carla Musso,Edna J. Nava-González,Francesco Negro,Alexander V. Nersesov,Brent A. Neuschwander-Tetri,Dafina Nikolova,Suzanne Norris,Katja Novak,Ponsiano Ocama,Janus P. Ong,Arlinking Ong-Go,Charles Onyekwere,Martin Padilla,Raluca Pais,Calvin Pan,Arturo Panduro,Manas K. Panigrahi,Georgios Papatheodoridis,Imran Paruk,Keyur Patel,Carlos Penha Gonçalves,Marlene Pérez Figueroa,Juanita Pérez-Escobar,Juan M. Pericàs,Gianluca Perseghin,Mário Guimarães Pessoa,Salvatore Petta,Claudia Pinto Marques Souza de Oliveira,Dorairaj Prabhakaran,Nikolaos Pyrsopoulous,Atoosa Rabiee,Alnoor Ramji,Vlad Ratziu,Natarajan Ravendhran,Katrina Ray,Michael Roden,Stefano Romeo,Manuel Romero-Gómez,Yaron Rotman,Samir Rouabhia,Ian A. Rowe,Shakhlo Sadirova,Maryam Salem Alkhatry,Riina Salupere,Sanjaya K. Satapathy,Jeffrey B. Schwimmer,Giada Sebastiani,Lynn Seim,Yosuke Seki,Abdel Karim Serme,David Shapiro,Lali Sharvadze,Jonathan E. Shaw,Isaac Thom Shawa,Thrivikrama Shenoy,Oren Shibolet,Yusuke Shimakawa,Jay H. Shubrook,Shivaram Prasad Singh,Edford Sinkala,Lubomir Skladany,Igor Skrypnyk,Myeong Jun Song,Silvia Sookoian,Kannan Sridharan,Norbert Stefan,Jonathan G. Stine,Nikolaos Stratakis,Dhastagir Sultan Sheriff,Shikha S. Sundaram,Gianluca Svegliati-Baroni,Mark G. Swain,Frank Tacke,Shahrad Taheri,Soek-Siam Tan,Elliot B. Tapper,Giovanni Targher,Eugen Tcaciuc,Maja Thiele,Dina Tiniakos,Ieva Tolmane,Aldo Torre,Esther A. Torres,Sombat Treeprasertsuk,Michael Trenell,Svetlana Turcan,Adela Turcanu,Jonas Valantinas,Laurens A. van Kleef,Jose Antonio Velarde Ruiz Velasco,Mette Vesterhus,Eduardo Vilar-Gomez,Waked,Julia Wattacheril,Heiner Wedemeyer,Fonda Wilkins,José Willemse,Robert J. Wong,Yusuf Yilmaz,Hannele Yki-Järvinen,Ming-Lung Yu,Volkan Yumuk,Müjdat Zeybel,Kenneth I. Zheng,Ming-Hua Zheng,Imam Waked
DOI: https://doi.org/10.1016/j.jhep.2023.04.035
IF: 25.7
2023-06-01
Journal of Hepatology
Abstract:BACKGROUND & AIMS: <AbstractText Label="BACKGROUND &amp; AIMS">An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community.</AbstractText>METHODS: <AbstractText Label="METHODS">Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a three-day in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy.</AbstractText>RESULTS: <AbstractText Label="RESULTS">The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of 'agree' responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement ('agree' + 'somewhat agree'); the remaining 23 priorities had &gt;90% combined agreement. While all but one of the priorities exhibited at least a super-majority of agreement (&gt;66.7% 'agree'), 13 priorities had &lt;80% 'agree', with greater reliance on 'somewhat agree' to achieve &gt;90% combined agreement.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS">Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community's efforts to advance and accelerate responses to this widespread and fast-growing public health threat.</AbstractText>IMPACT AND IMPLICATIONS: <AbstractText Label="IMPACT AND IMPLICATIONS">An estimated 38% of adults and 13% of children and adolescents worldwide have fatty liver disease, making it the most prevalent liver disease in history. Despite substantial scientific progress in the past three decades, the burden continues to grow, with an urgent need to advance understanding of how to prevent, manage, and treat the disease. Through a global consensus process, a multidisciplinary group agreed on 28 research priorities covering a broad range of themes, from disease burden, treatment, and health system responses to awareness and policy. The findings have relevance for clinical and non-clinical researchers as well as funders working on fatty liver disease and non-communicable diseases more broadly, setting out a prioritised, ranked research agenda for turning the tide on this fast-growing public health threat.</AbstractText>
gastroenterology & hepatology